Cogent Biosciences (COGT) Net Margin (2017 - 2020)
Cogent Biosciences (COGT) posted quarterly Net Margin of 20362.82% for Q3 2020, down 1919390.0% year-over-year from N/an in Q4 2019, and down 1352.91% quarter-over-quarter from 1401.52% in Q2 2020.
Powered by 
Analysis
Cogent Biosciences (COGT) Net Margin (2017 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has reported Net Margin for 4 consecutive years, with 20362.82% the latest figure, recorded in Q3 2020.
- In Q3 2020, Net Margin fell 1919390.0% year-over-year to 20362.82%; the TTM figure through Dec 2020 stood at 1133.54% (down 99205.0% YoY), while the FY2020 annual figure was 1090.23%, down 94874.0% from the prior year.
- Net Margin retreated to 20362.82% in Q3 2020 per COGT's latest filing, from 1401.52% in the prior quarter.
- Across five years, Net Margin topped out at 15.02% in Q4 2019 and bottomed at 20362.82% in Q3 2020.
- Historically, Net Margin has averaged 1767.88% across 4 years, with a median of 325.94% in 2017.
- On a YoY basis, Net Margin climbed as much as 29626 bps in 2020 and fell as far as 1919390 bps in 2020.
- Cogent Biosciences' Net Margin stood at 315.87% in 2017, then gained by 28 bps to 226.18% in 2018, then jumped by 107 bps to 15.02% in 2019, then sank by 135628 bps to 20362.82% in 2020.
- Business Quant data shows COGT's Net Margin at 20362.82% in Q3 2020, 1401.52% in Q2 2020, and 86.67% in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 12.09% |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -3.12% |
| 10 | Cogent Biosciences | 5.93 Bn | 5.93 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -18,325.64% |
| Jun 30, 2020 | -1,401.52% |
| Mar 31, 2020 | -86.67% |
| Dec 31, 2019 | 15.02% |
| Sep 30, 2019 | -1,168.92% |
| Jun 30, 2019 | -335.12% |
| Mar 31, 2019 | -382.93% |
| Dec 31, 2018 | -226.18% |
| Sep 30, 2018 | -497.70% |
| Jun 30, 2018 | -541.60% |
| Mar 31, 2018 | -304.10% |
| Dec 31, 2017 | -315.87% |
| Sep 30, 2017 | -300.99% |
| Jun 30, 2017 | -282.83% |
| Mar 31, 2017 | -325.94% |